FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159136952> ?p ?o ?g. }

• W2159136952 endingPage "1105" @default.
• W2159136952 startingPage "1099" @default.
• W2159136952 abstract "Angiotensin II type-1 receptor blockers are widely used with the expectation of prevention of stroke, potential effects to ameliorate of type-2 diabetes, which seems to be closely associated with the impairment of cognitive function in humans. Recently, we have reported that an angiotensin II type-1 receptor blocker prevented cognitive impairment in mice after focal cerebral ischemia, at least partly through an angiotensin II type-2 receptor-mediated increase in a neuroprotective factor, methyl methanesulfonate sensitive-2. Here, we examined the possibility that an angiotensin II type-1 receptor blocker could improve cognitive function in a type-2 diabetic mouse model, KK-A(y). KK-A(y) mice subjected to 20 trials of a passive avoidance task every week from 8 weeks exhibited a significantly impaired avoidance rate, and moreover, its age-dependent decline, especially after 14 weeks of age, compared with age-matched C57BL6 mice. Oral administration of candesartan at a nonhypotensive dose (0.005% in laboratory chow) in KK-A(y) mice improved cognitive function and inhibited the impairment of cognitive decline. Methyl methanesulfonate sensitive-2 expression in the brain was lower in KK-A(y) mice than in C57BL6 mice. Treatment with candesartan markedly increased mRNA expression of angiotensin II type-2 receptor and methyl methanesulfonate sensitive-2 in the brain in KK-A(y) mice, determined by quantitative RT-PCR. In KK-A(y) mice treated with candesartan, age-dependent increases in blood glucose and insulin were significantly suppressed. Our results suggest that candesartan ameliorates the impaired cognitive function in type-2 diabetes mice, at least because of an increased expression of methyl methanesulfonate sensitive-2, a neuroprotective factor, in addition to improvement of glucose intolerance." @default.
• W2159136952 created "2016-06-24" @default.
• W2159136952 creator A5001563356 @default.
• W2159136952 creator A5011935809 @default.
• W2159136952 creator A5012868995 @default.
• W2159136952 creator A5029441816 @default.
• W2159136952 creator A5049688470 @default.
• W2159136952 creator A5061785517 @default.
• W2159136952 creator A5078970144 @default.
• W2159136952 creator A5083595001 @default.
• W2159136952 creator A5083720055 @default.
• W2159136952 date "2007-12-01" @default.
• W2159136952 modified "2023-10-13" @default.
• W2159136952 title "Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan" @default.
• W2159136952 cites W150222691 @default.
• W2159136952 cites W180946569 @default.
• W2159136952 cites W1965801493 @default.
• W2159136952 cites W1978722589 @default.
• W2159136952 cites W1983441877 @default.
• W2159136952 cites W1988206467 @default.
• W2159136952 cites W1989104104 @default.
• W2159136952 cites W1991030758 @default.
• W2159136952 cites W1994929956 @default.
• W2159136952 cites W1999055613 @default.
• W2159136952 cites W2011643486 @default.
• W2159136952 cites W2012719211 @default.
• W2159136952 cites W2014788105 @default.
• W2159136952 cites W2019767570 @default.
• W2159136952 cites W2028212562 @default.
• W2159136952 cites W2040699222 @default.
• W2159136952 cites W2044437167 @default.
• W2159136952 cites W2048584554 @default.
• W2159136952 cites W2048780387 @default.
• W2159136952 cites W2058473463 @default.
• W2159136952 cites W2062426826 @default.
• W2159136952 cites W2073735186 @default.
• W2159136952 cites W2083990676 @default.
• W2159136952 cites W2086199925 @default.
• W2159136952 cites W2114456718 @default.
• W2159136952 cites W2119301405 @default.
• W2159136952 cites W2130693276 @default.
• W2159136952 cites W2131430447 @default.
• W2159136952 cites W2133217116 @default.
• W2159136952 cites W2135038122 @default.
• W2159136952 cites W2146798390 @default.
• W2159136952 cites W2160654062 @default.
• W2159136952 cites W2168276527 @default.
• W2159136952 cites W2168610437 @default.
• W2159136952 cites W2172032309 @default.
• W2159136952 doi "https://doi.org/10.1161/hypertensionaha.107.099374" @default.
• W2159136952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17968000" @default.
• W2159136952 hasPublicationYear "2007" @default.
• W2159136952 type Work @default.
• W2159136952 sameAs 2159136952 @default.
• W2159136952 citedByCount "37" @default.
• W2159136952 countsByYear W21591369522012 @default.
• W2159136952 countsByYear W21591369522013 @default.
• W2159136952 countsByYear W21591369522014 @default.
• W2159136952 countsByYear W21591369522015 @default.
• W2159136952 countsByYear W21591369522016 @default.
• W2159136952 countsByYear W21591369522017 @default.
• W2159136952 countsByYear W21591369522019 @default.
• W2159136952 countsByYear W21591369522020 @default.
• W2159136952 countsByYear W21591369522022 @default.
• W2159136952 crossrefType "journal-article" @default.
• W2159136952 hasAuthorship W2159136952A5001563356 @default.
• W2159136952 hasAuthorship W2159136952A5011935809 @default.
• W2159136952 hasAuthorship W2159136952A5012868995 @default.
• W2159136952 hasAuthorship W2159136952A5029441816 @default.
• W2159136952 hasAuthorship W2159136952A5049688470 @default.
• W2159136952 hasAuthorship W2159136952A5061785517 @default.
• W2159136952 hasAuthorship W2159136952A5078970144 @default.
• W2159136952 hasAuthorship W2159136952A5083595001 @default.
• W2159136952 hasAuthorship W2159136952A5083720055 @default.
• W2159136952 hasBestOaLocation W21591369521 @default.
• W2159136952 hasConcept C104849204 @default.
• W2159136952 hasConcept C126322002 @default.
• W2159136952 hasConcept C134018914 @default.
• W2159136952 hasConcept C170493617 @default.
• W2159136952 hasConcept C25498285 @default.
• W2159136952 hasConcept C2777180221 @default.
• W2159136952 hasConcept C2779134260 @default.
• W2159136952 hasConcept C2779483572 @default.
• W2159136952 hasConcept C2780036600 @default.
• W2159136952 hasConcept C2908929049 @default.
• W2159136952 hasConcept C2984863031 @default.
• W2159136952 hasConcept C555293320 @default.
• W2159136952 hasConcept C71924100 @default.
• W2159136952 hasConceptScore W2159136952C104849204 @default.
• W2159136952 hasConceptScore W2159136952C126322002 @default.
• W2159136952 hasConceptScore W2159136952C134018914 @default.
• W2159136952 hasConceptScore W2159136952C170493617 @default.
• W2159136952 hasConceptScore W2159136952C25498285 @default.
• W2159136952 hasConceptScore W2159136952C2777180221 @default.
• W2159136952 hasConceptScore W2159136952C2779134260 @default.
• W2159136952 hasConceptScore W2159136952C2779483572 @default.
• W2159136952 hasConceptScore W2159136952C2780036600 @default.
• W2159136952 hasConceptScore W2159136952C2908929049 @default.

• next